Reference Type:  Journal Article
Record Number: 304
Author: Jun, G., Naj, A. C., Beecham, G. W., Wang, L. S., Buros, J., Gallins, P. J., Buxbaum, J. D., Ertekin-Taner, N., Fallin, M. D., Friedland, R., Inzelberg, R., Kramer, P., Rogaeva, E., St George-Hyslop, P., Cantwell, L. B., Dombroski, B. A., Saykin, A. J., Reiman, E. M., Bennett, D. A., Morris, J. C., Lunetta, K. L., Martin, E. R., Montine, T. J., Goate, A. M., Blacker, D., Tsuang, D. W., Beekly, D., Cupples, L. A., Hakonarson, H., Kukull, W., Foroud, T. M., Haines, J., Mayeux, R., Farrer, L. A., Pericak-Vance, M. A., Schellenberg, G. D., Arnold, S. E., Baldwin, C. T., Barber, R., Beach, T., Bigio, E. H., Bird, T. D., Boxer, A., Burke, J. R., Cairns, N., Carroll, S. L., Chui, H. C., Clark, D. G., Cotman, C. W., Cummings, J. L., Decarli, C., Diaz-Arrastia, R., Dick, M., Dickson, D. W., Ellis, W. G., Fallon, K. B., Farlow, M. R., Ferris, S., Frosch, M. P., Galasko, D. R., Gearing, M., Geschwind, D. H., Ghetti, B., Gilman, S., Giordani, B., Glass, J., Graff-Radford, N. R., Green, R. C., Growdon, J. H., Hamilton, R. L., Harrell, L. E., Head, E., Honig, L. S., Hulette, C. M., Hyman, B. T., Jicha, G. A., Jin, L. W., Johnson, N., Karlawish, J., Karydas, A., Kaye, J. A., Kim, R., Koo, E. H., Kowall, N. W., Lah, J. J., Levey, A. I., Lieberman, A., Lopez, O. L., Mack, W. J., Markesbery, W., Marson, D. C., Martiniuk, F., Masliah, E., McKee, A. C., Mesulam, M., Miller, J. W., Miller, B. L., Miller, C. A., Parisi, J. E., Perl, D. P., Peskind, E., Petersen, R. C., Poon, W., Quinn, J. F., Raskind, M., Reisberg, B., Ringman, J. M., Roberson, E. D., Rosenberg, R. N., Sano, M., Schneider, J. A., Schneider, L. S., Seeley, W., Shelanski, M. L., Smith, C. D., Spina, S., Stern, R. A., Tanzi, R. E., Trojanowski, J. Q., Troncoso, J. C., Van Deerlin, V. M., Vinters, H. V., Vonsattel, J. P., Weintraub, S., Welsh-Bohmer, K. A., Woltjer, R. L. and Younkin, S. G.
Year: 2010
Title: Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes
Journal: Arch Neurol
Volume: 67
Issue: 12
Pages: 1473-84
Epub Date: 2010/08/11
Date: Aug 9
Short Title: Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes
ISSN: 1538-3687 (Electronic)
0003-9942 (Linking)
DOI: archneurol.2010.201 [pii]
10.1001/archneurol.2010.201
Accession Number: 20697030
Abstract: OBJECTIVES: To determine whether genotypes at CLU, PICALM, and CR1 confer risk for Alzheimer disease (AD) and whether risk for AD associated with these genes is influenced by apolipoprotein E (APOE) genotypes. DESIGN: Association study of AD and CLU, PICALM, CR1, and APOE genotypes. SETTING: Academic research institutions in the United States, Canada, and Israel. PARTICIPANTS: Seven thousand seventy cases with AD, 3055 with autopsies, and 8169 elderly cognitively normal controls, 1092 with autopsies, from 12 different studies, including white, African American, Israeli-Arab, and Caribbean Hispanic individuals. RESULTS: Unadjusted, CLU (odds ratio [OR], 0.91; 95% confidence interval [CI], 0.85-0.96 for single-nucleotide polymorphism [SNP] rs11136000), CR1 (OR, 1.14; 95% CI, 1.07-1.22; SNP rs3818361), and PICALM (OR, 0.89; 95% CI, 0.84-0.94, SNP rs3851179) were associated with AD in white individuals. None were significantly associated with AD in the other ethnic groups. APOE epsilon4 was significantly associated with AD (ORs, 1.80-9.05) in all but 1 small white cohort and in the Arab cohort. Adjusting for age, sex, and the presence of at least 1 APOE epsilon4 allele greatly reduced evidence for association with PICALM but not CR1 or CLU. Models with the main SNP effect, presence or absence of APOE epsilon4, and an interaction term showed significant interaction between presence or absence of APOE epsilon4 and PICALM. CONCLUSIONS: We confirm in a completely independent data set that CR1, CLU, and PICALM are AD susceptibility loci in European ancestry populations. Genotypes at PICALM confer risk predominantly in APOE epsilon4-positive subjects. Thus, APOE and PICALM synergistically interact.
Notes: Alzheimer's Disease Genetics Consortium
Journal article
Archives of neurology
Arch Neurol. 2010 Aug 9.
URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20697030
Author Address: Ophthalmology (Dr Jun), Biostatistics (Drs Jun, Lunetta, and Cupples), Neurology (Dr Farrer), and Genetics and Genomics and Epidemiology (Dr Farrer), Boston University, Boston, and Department of Psychiatry and Epidemiology (Dr Blacker), Massachusetts General Hospital, Charlestown; The John P. Hussman Institute for Human Genomics (Drs Naj, Beecham, and Pericak-Vance and Mr Gallins) and Dr John T. Macdonald Foundation Department of Human Genetics (Drs Beecham, Martin, and Pericak-Vance), University of Miami, Miami, and Departments of Neuroscience and Neurology, Mayo Clinic Jacksonville, Jacksonville (Dr Ertekin-Taner), Florida; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine (Drs Wang, Dombroski, and Schellenberg and Ms Cantwell), and Center for Applied Genomics, Children's Hospital of Philadelphia (Dr Hakonarson), Philadelphia; Departments of Psychiatry, Neuroscience, and Genetics and Genomic Sciences, Mount Sinai School of Medicine (Dr Buxbaum), and Sergievsky Center and Taub Institute (Dr Mayeux), Columbia University, New York, New York; Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland (Dr Fallin); Department of Neurology, University of Louisville, Louisville, Kentucky (Dr Friedland); Sheba Medical Center, Departments of Neurology and Medicine, Tel Aviv University, Israel (Dr Inzelberg); Departments of Neurology and Molecular and Medical Genetics, Oregon Health and Science University, Portland (Dr Kramer); Centre for Research in Neurodegenerative Diseases, Department of Medicine, University of Toronto, Toronto, Ontario, Canada (Drs Rogaeva and St. George-Hyslop); Cambridge Institute for Medical Research, Department of Clinical Neurosciences, University of Cambridge, Cambridge, England (Dr St. George-Hyslop); Departments of Radiology and Imaging Sciences (Dr Saykin) and Medical and Molecular Genetics (Drs Saykin and Foroud), Indiana University, Indianapolis; Arizona Alzheimer's Consortium and Banner Alzheimer's Institute and Neurogenomics Division, Translational Genomics Research Institute and Department of Psychiatry, University of Arizona, Phoenix (Dr Reiman); Rush Alzheimer's Disease Center and Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois (Dr Bennett); Departments of Neurology (Dr Morris), Pathology and Immunology (Dr Morris), and Psychiatry (Dr Goate), Washington University, St Louis, Missouri; Departments of Pathology (Dr Montine) and Psychiatry and Behavioral Sciences (Dr Tsuang), National Alzheimer's Coordinating Center (Mr Beekly and Dr Kukull), and Department of Epidemiology, University of Washington (Dr Kukull), Seattle; and Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee (Dr Haines).
Language: Eng

